Elite Pharmaceuticals Delivers Strong FY 2024 Financial Performance
Monday, 1 July 2024, 21:10
Elite Pharmaceuticals FY 2024 Financial Results
Elite Pharmaceuticals has announced its financial performance for the fiscal year 2024, highlighting significant achievements in revenue and profits.
Key Points:
- Record Revenue: Elite Pharmaceuticals recorded revenue of $56.6 million.
- Operating Profits Surge: Operating profits increased by 192% compared to the previous fiscal year.
This strong performance reflects Elite Pharmaceuticals' solid growth and financial strength in the pharmaceutical sector.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.